HEALTH DEBACLE
12/01/22 -"Health stocks (ex-Pharma) are competing with Semi-Conductors for the biggest loser spot. This is the by-product of trading at impossible multiples when the Fed is changing the game and raising rates. ..."
Pages
50
Language
English
Published on
12/01/22
You may also be interested by these reports :
20/01/26
Virbac ended 2025 on a strong note, with sales growth (at CERS) exceeding the management’s guidance that was upgraded only in October 2025. The ...
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
09/01/26
Hikma, over the years, has struggled to create shareholder wealth, perhaps because of its inability (until now) to develop biosimilars on its own. ...
31/12/25
Keeping in mind the underwhelming late-stage results of the immunology drug, amlitelimab, and a few other R&D setbacks in recent years, we have ...